Access cutting-edge retroperitoneal sarcoma treatment through this clinical trial at a research site in Guilford. Study-provided care at no cost to qualified participants.
Access retroperitoneal sarcoma specialists in Guilford at no cost
This study follows strict safety protocols and ethical guidelines
All study-related retroperitoneal sarcoma treatment provided free
This is a multicenter, randomized, open label phase lll trial to assess whether preoperative chemotherapy, as an adjunct to curative-intent surgery, improves the prognosis of high risk DDLPS (dedifferentiated Liposarcoma) and LMS (Leiomyosarcoma) patients as measured by disease free survival. After confirmation of eligibility criteria, patients will be randomized to either the standard arm or experimental arm.
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Check if you qualify for this retroperitoneal sarcoma clinical trial in Guilford, CT
If you're searching for retroperitoneal sarcoma treatment options in Guilford, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Guilford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced retroperitoneal sarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.